We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Robotic Platform Enables More Accurate Diagnosis of Cancer Cells

By LabMedica International staff writers
Posted on 25 Oct 2023

For more than a century, the field of histology, which falls under pathology and focuses on changes in tissue, has relied on an old-school method. This involves slicing tissue samples into extremely thin sections—each about seven times thinner than a human hair—and then examining them for any abnormal changes under a microscope. The downside of this traditional technique is that it leads to misdiagnosis in about one out of every six people, often missing cancer cells. Now, scientists have integrated biomedical technology with mechanical engineering to create a robotic system that not only diagnoses cancer more precisely but also offers three-dimensional insights into the spatial arrangement of cells.

Researchers from ETH Zurich (Zurich, Switzerland) and the University of Zurich (Zurich, Switzerland) are working on this robotic platform designed to improve the accuracy of cancer diagnosis by rapidly quantifying tissue samples in their entirety. The procedure involves four stages. First, the tissue sample is automatically made transparent. Second, any unusual cells are quickly stained or colored. The third phase consists of generating a 3D image that maps out the cancer cells; the technology for this is already available. The last phase involves analyzing the tissue using 3D imaging software and training algorithms. This novel approach eliminates the need for labor-intensive preparation and slicing of tissue samples; instead, the entire tissue sample—like a lymph node—is preserved and fully examined. The 3D digital images showing the marked cells can be accessed online whenever needed.

Currently, the robot prototype is functional in the lab and can maneuver samples as required. However, it's not yet completely market-ready. While the team can provide preliminary services like automatically rendering sent-in tissue samples transparent and generating labeled 3D images swiftly, the software still needs fine-tuning. The researchers aim to commercialize this robotic system, offering research laboratories and healthcare facilities a dependable and effective tool that could revolutionize the way cancer diagnosis is conducted in the digital age.

Related Links:
ETH Zurich 
University of Zurich 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.